Reference library

C-Peptide Test Cost: HPLC & LC-MS Pricing

What a c-peptide test costs: $75–$150 for HPLC purity, $150–$350 for LC-MS ID, $450–$900 for full characterization, plus vial prices and rush fees.

A third-party HPLC purity assay on a C-peptide reference material typically runs $75–$150 per sample; LC-MS identity confirmation adds $150–$350; a full characterization panel (RP-HPLC purity, mass confirmation, amino acid analysis, water content, counter-ion, residual solvents) lands between $450 and $900 at most US contract labs, with 5–10 business day turnaround and a 1.5–2× surcharge for 48-hour rush. The material itself — human C-peptide, 31 residues, ~3020 Da, lyophilized — generally sells at $55–$110 for a 5 mg vial at single-unit pricing, with per-mg cost falling 30–50% at 10-vial quantities. If your supplier already provides a lot-specific certificate of analysis, most of that testing spend is redundant.

One disambiguation before you read further: if you arrived looking for the price of a clinical C-peptide blood draw, that is a diagnostic service billed by a medical laboratory and ordered by a clinician. This page is about the cost of analytically characterizing C-peptide as a research reference material. Different product, different buyer, different regulations. Nothing here applies to a patient sample.

What the analytical work actually costs, line by line

Contract lab pricing in the US clusters tightly. These are single-sample, non-contract rates as of 2026; annual-volume agreements commonly cut 15–25%.

  • RP-HPLC purity (UV 214/280 nm, gradient method): $75–$150. The most common single test ordered. Includes a chromatogram and an area-percent figure. Method development, if the lab does not already have a C-peptide method on file, is billed separately at $600–$2,500.
  • ESI-MS or MALDI-TOF identity: $150–$350. Confirms the observed monoisotopic or average mass against the theoretical ~3020 Da. Cheap insurance against a mislabeled or substituted lot.
  • Amino acid analysis (AAA): $200–$400. The only method that gives a defensible net peptide content number rather than a chromatographic purity percentage. Frequently skipped and frequently the one that matters.
  • Karl Fischer water content: $80–$160. Lyophilized peptide routinely carries 4–10% residual water by mass.
  • Ion chromatography for TFA counter-ion: $100–$200. Trifluoroacetate salt can account for another 5–15% of vial mass.
  • Residual solvents by GC-MS (acetonitrile, methanol, DMF): $150–$275.
  • Endotoxin (LAL, kinetic chromogenic): $75–$140 per sample, only relevant for cell-based work.
  • Peptide mapping / MS-MS sequence confirmation: $700–$1,800. Rarely justified for a 31-mer with an unambiguous parent mass.

Add shipping a sample on dry ice — $60–$180 per outbound package domestically — and a full outside panel on one lot realistically costs $550 to $1,100 all-in, against a vial that cost $80.

Why the per-milligram price on the invoice is not the real number

A 5 mg vial labeled 98% purity does not contain 5 mg of C-peptide. Work the arithmetic:

  • 5.0 mg gross vial contents
  • minus 7% water (typical, Karl Fischer) → 4.65 mg
  • minus 9% TFA counter-ion → 4.23 mg
  • times 98% chromatographic purity → 4.15 mg of actual peptide

Your $80 vial is $19.28 per effective mg, not $16.00 — a 20% gap. Two suppliers quoting $80 and $95 can invert once net peptide content is known, and the only way to know it is AAA or a supplier who reports it on the certificate. A lot at 96% HPLC with 3% water and 4% TFA delivers more peptide than a "99%" lot at 11% water and 14% TFA.

The cheapest defensible C-peptide is almost never the cheapest vial. It's the vial whose certificate of analysis lets you skip $600 of confirmatory testing.

What a certificate of analysis has to contain to save you money

A COA that says "Purity: >98%" with no lot number, no date, and no chromatogram saves you nothing — you will re-test, and you should. A COA worth its weight includes:

  • A lot or batch number that appears on both the document and the vial label
  • The actual chromatogram image, with retention time, gradient conditions, column chemistry and dimensions, injection volume, and detection wavelength
  • The mass spectrum with observed vs. theoretical mass and charge states
  • Water content and counter-ion content, reported numerically, not as "not detected"
  • Analysis date and analyst or lab identity — an in-house COA is fine if the method is disclosed; a third-party COA from a named lab is stronger
  • A retest or expiry date, typically 24–36 months from manufacture for a sealed lyophilized vial stored at −20 °C

Our approach to lot documentation is described on the quality page, and the framing that governs how all of this material may be used is on research use only.

When paying for your own testing is a waste of money

This is the part that costs us margin to say plainly.

You do not need a $900 panel if: you are running a method-development or column-conditioning experiment where identity is confirmed in-run by your own LC-MS, your assay tolerates ±10% on concentration, or you are consuming under 10 mg per year. In that case, buy the vial, run one 20 µL injection on your own system, compare retention time and mass to the supplier chromatogram, and move on. That costs you roughly $8–$25 in solvent, column lifetime, and instrument time.

You should not order a rush panel at 2× rate unless a grant deadline or an audit date genuinely forces it. The 48-hour surcharge on a $700 panel is $700 for two saved days.

Peptide mapping on a 31-mer is usually overspending. A clean parent-ion mass plus a single sharp HPLC peak answers the identity question. Mapping earns its $1,200 when you suspect deamidation, oxidation, or a specific sequence variant — not as a default.

Endotoxin testing is irrelevant to most chemistry. If the material never touches a cell, that $110 buys nothing.

Certified reference materials (CRMs) are a different price tier entirely. A metrologically traceable, ISO 17034-accredited C-peptide CRM can run $400–$1,400 for 0.5–1 mg, sometimes 20× the per-mg cost of research-grade material. If you are calibrating a quantitative assay whose results will be compared across institutions, that premium is the point and research-grade material is the wrong purchase. If you are not, you are paying for a traceability chain you will never invoke.

Who should not buy this at all

  • Anyone seeking a clinical result about a person. Reference material is not a diagnostic service and cannot substitute for one. Ordering a vial in place of a lab test is a category error.
  • Anyone without −20 °C storage. Lyophilized C-peptide left at ambient temperature for weeks is a degraded, undocumented material, and no COA covers what happened after the box was opened. Cold-chain inbound is only half the problem.
  • Anyone who needs GMP material. Research-use material has no GMP pedigree, no regulatory dossier, and no route to becoming either. GMP C-peptide is a separate supply chain at 10–100× the cost.
  • Buyers under $500/year of consumption who are shopping three suppliers on price. The 20 minutes of comparison will exceed the savings.
  • Anyone who cannot document chain of custody for their own downstream records. If the vial's lot number never makes it into your notebook, the certificate was a formality.

Failure modes that quietly inflate the real cost

Repeat-purchase spend gets destroyed by things that never appear on a quote.

  • Lot-to-lot drift. A supplier who ships lot A at 98.4% and lot B at 94.1% forces re-qualification every order. Two re-tests a year at $250 each is $500 of hidden annual cost that a $10-cheaper vial does not offset.
  • Reused COAs. A document dated 2023 attached to a 2026 shipment is not a lot certificate. Check that the analysis date is later than the manufacture date and within the retest window.
  • Freeze-thaw of the shipment in transit. Dry ice sublimating out on day 3 of a 4-day ground transit means the material arrived warm. Ask what the packout is rated for and whether a temperature indicator is included; details are on shipping.
  • Vial underfill. Fill tolerance of ±10% on a 5 mg vial is common and rarely disclosed. Gravimetric verification on receipt costs you nothing but a balance reading.
  • Method mismatch. A supplier reporting purity at 220 nm on a 5 µm C18 and your lab reporting at 214 nm on a 1.7 µm C18 will disagree by 1–3% for reasons that have nothing to do with the material.

A realistic annual budget

A small lab consuming 50 mg of C-peptide per year, buying at 10-vial pricing, qualifying one new lot annually with an outside HPLC + MS check, and paying cold-chain freight four times:

  • Material: 10 × 5 mg at ~$60/vial = $600
  • One outside confirmation (HPLC + MS): $275
  • Freight, 4 shipments at $45–$95: $180–$380
  • Total: $1,055–$1,255/year

The same lab running a full panel on every lot instead: add roughly $2,400–$3,600, for information that the supplier's own certificate already supplied. Spend that on a second lot for cross-comparison instead — it answers more questions.

If you want the actual lot documentation for current inventory before committing to a PO, ask for it through contact; a supplier who will not send a redacted sample COA pre-purchase is telling you something about the one you would receive after.


Supplied strictly for in-vitro laboratory research by qualified researchers and institutions. Not a drug, food, cosmetic or dietary supplement. Not for human or veterinary consumption. Not evaluated by the FDA.

Every batch ships with its own certificate.

Purity, identity and lot number, documented for the exact vial you receive.

How we test